CAPTOPRIL

CAPTOPRIL was reported 9624 times

CAPTOPRIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEGMENTAL DIVERTICULAR COLITIS 20 0.5556
1 CARDIOPULMONARY EXERCISE TEST ABNORMAL 13 0.4643
2 PEDAL PULSE ABNORMAL 20 0.3448
3 MENISCOPATHY 12 0.2667
4 PELVIC MISALIGNMENT 12 0.2353
5 FACTOR VII DEFICIENCY 14 0.2090
6 PERONEAL NERVE INJURY 13 0.1150
7 SACROILIAC JOINT DYSFUNCTION 13 0.0977
8 NEUROFIBROMA 14 0.0933
9 CALCIUM IONISED DECREASED 20 0.0823
10 SCLERODERMA RENAL CRISIS 25 0.0658
11 LABILE HYPERTENSION 15 0.0543
12 MERYCISM 14 0.0490
13 FEEDING INTOLERANCE 21 0.0466
14 INSULIN AUTOIMMUNE SYNDROME 15 0.0420
15 KIDNEY SMALL 10 0.0341
16 MYOSCLEROSIS 12 0.0325
17 PATELLOFEMORAL PAIN SYNDROME 14 0.0272
18 HELICOBACTER TEST POSITIVE 15 0.0267
19 REDUCED FACIAL EXPRESSION 27 0.0266
20 JOINT HYPEREXTENSION 10 0.0256
21 VESTIBULAR NEURONITIS 13 0.0243
22 NEUROGENIC SHOCK 13 0.0239
23 CERVICOBRACHIAL SYNDROME 14 0.0228
24 ORTHOSTATIC INTOLERANCE 16 0.0223
25 STASIS DERMATITIS 14 0.0205
26 RENAL ISCHAEMIA 11 0.0201
27 BLOOD GROWTH HORMONE INCREASED 10 0.0179
28 SOLAR LENTIGO 15 0.0158
29 EXTENSOR PLANTAR RESPONSE 14 0.0152
30 BLOOD KETONE BODY INCREASED 11 0.0141
31 PULMONARY HYPOPLASIA 11 0.0140
32 OSTEOCHONDROSIS 16 0.0138
33 AORTIC DILATATION 15 0.0135
34 THERAPEUTIC PRODUCT CROSS-REACTIVITY 12 0.0134
35 LEFT VENTRICULAR HYPERTROPHY 52 0.0121
36 PULMONARY VALVE INCOMPETENCE 17 0.0116
37 GINGIVAL HYPERTROPHY 16 0.0105
38 NODAL RHYTHM 15 0.0102
39 VENOUS OCCLUSION 18 0.0099
40 AORTIC VALVE INCOMPETENCE 41 0.0096
41 KNEE DEFORMITY 14 0.0094
42 MONOPARESIS 17 0.0094
43 CARDIOACTIVE DRUG LEVEL INCREASED 12 0.0091
44 ORTHOPNOEA 29 0.0091
45 LISTLESS 30 0.0091
46 DILATATION VENTRICULAR 19 0.0090
47 NEOPLASM SKIN 14 0.0090
48 PERIARTHRITIS 20 0.0088
49 APRAXIA 13 0.0088
50 CONDUCTION DISORDER 16 0.0087
51 RHONCHI 12 0.0087
52 INFARCTION 58 0.0085
53 VENTRICULAR HYPERTROPHY 21 0.0084
54 OBSTRUCTIVE SLEEP APNOEA SYNDROME 12 0.0082
55 BLOOD PRESSURE INADEQUATELY CONTROLLED 49 0.0081
56 RENAL ARTERY STENOSIS 11 0.0080
57 LEFT ATRIAL DILATATION 10 0.0078
58 HYPERTENSIVE CRISIS 83 0.0075
59 CHRONIC RESPIRATORY FAILURE 9 0.0075
60 CHONDROPATHY 20 0.0074
61 DERMATITIS EXFOLIATIVE 36 0.0072
62 BRONCHIOLITIS 25 0.0071
63 ADENOCARCINOMA PANCREAS 9 0.0070
64 AORTIC VALVE DISEASE 11 0.0068
65 BRONCHOPNEUMONIA 22 0.0064
66 NOSOCOMIAL INFECTION 14 0.0063
67 KLEBSIELLA INFECTION 32 0.0063
68 INTERMITTENT CLAUDICATION 10 0.0063
69 LIMB DEFORMITY 10 0.0063
70 TRICUSPID VALVE INCOMPETENCE 50 0.0063
71 DIABETES MELLITUS NON-INSULIN-DEPENDENT 9 0.0062
72 ACTINIC KERATOSIS 16 0.0062
73 ANGIOPLASTY 9 0.0060
74 RESUSCITATION 10 0.0060
75 THERAPEUTIC AGENT TOXICITY 20 0.0060
76 DEMENTIA ALZHEIMER'S TYPE 10 0.0060
77 OLIGURIA 37 0.0060
78 CARDIOMEGALY 73 0.0059
79 PARKINSON'S DISEASE 15 0.0059
80 VASCULAR STENT THROMBOSIS 12 0.0059
81 BUNDLE BRANCH BLOCK LEFT 25 0.0059
82 LONG QT SYNDROME 14 0.0058
83 PARESIS 13 0.0058
84 CORONARY ARTERY STENOSIS 29 0.0058
85 MULTI-ORGAN FAILURE 98 0.0057
86 ANGIONEUROTIC OEDEMA 15 0.0056
87 NEPHROGENIC SYSTEMIC FIBROSIS 17 0.0056
88 COSTOCHONDRITIS 9 0.0055
89 MIGRAINE WITH AURA 15 0.0055
90 DIASTOLIC DYSFUNCTION 17 0.0055
91 IMMOBILE 24 0.0055
92 ELECTROLYTE IMBALANCE 63 0.0054
93 LOBAR PNEUMONIA 10 0.0054
94 VENTRICULAR DYSFUNCTION 14 0.0054
95 ANGIOPATHY 30 0.0053
96 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
97 VENTRICULAR EXTRASYSTOLES 54 0.0052
98 CAROTID ARTERY STENOSIS 18 0.0051
99 LABYRINTHITIS 13 0.0051
100 ATROPHY 10 0.0051
101 CARDIAC MURMUR 44 0.0051
102 SELF-INJURIOUS IDEATION 21 0.0050
103 ISCHAEMIA 23 0.0050
104 CYANOSIS 78 0.0050
105 MITRAL VALVE INCOMPETENCE 56 0.0049
106 RENAL FAILURE CHRONIC 38 0.0049
107 TOXIC EPIDERMAL NECROLYSIS 74 0.0049
108 IMPULSE-CONTROL DISORDER 10 0.0049
109 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
110 DYSENTERY 9 0.0048
111 CONGESTIVE CARDIOMYOPATHY 20 0.0048
112 TONGUE OEDEMA 18 0.0047
113 DIABETIC NEUROPATHY 23 0.0046
114 ANGINA UNSTABLE 30 0.0046
115 BUNDLE BRANCH BLOCK RIGHT 21 0.0046
116 AREFLEXIA 12 0.0045
117 CHOLESTATIC LIVER INJURY 10 0.0045
118 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
119 MULTIPLE INJURIES 28 0.0044
120 SUPRAVENTRICULAR EXTRASYSTOLES 15 0.0044
121 GASTROINTESTINAL SOUNDS ABNORMAL 22 0.0044
122 BLOOD UREA INCREASED 74 0.0044
123 PULSE ABSENT 21 0.0044
124 KOUNIS SYNDROME 10 0.0044
125 LICHENOID KERATOSIS 10 0.0044
126 VENTRICULAR ARRHYTHMIA 16 0.0044
127 DENGUE FEVER 10 0.0044
128 VENTRICULAR HYPOKINESIA 14 0.0044
129 LEFT VENTRICULAR FAILURE 15 0.0044
130 CARDIAC FAILURE ACUTE 29 0.0043
131 SKIN EROSION 14 0.0043
132 HAEMODYNAMIC INSTABILITY 33 0.0043
133 DIABETIC COMPLICATION 11 0.0043
134 THROMBOTIC THROMBOCYTOPENIC PURPURA 15 0.0043
135 FOREIGN BODY 17 0.0042
136 CHEST X-RAY ABNORMAL 13 0.0042
137 CONCOMITANT DISEASE AGGRAVATED 26 0.0042
138 HEART VALVE INCOMPETENCE 12 0.0042
139 ARTERIOSCLEROSIS CORONARY ARTERY 27 0.0041
140 AORTIC STENOSIS 14 0.0040
141 CEREBRAL ATROPHY 16 0.0040
142 AZOTAEMIA 16 0.0040
143 NORMOCHROMIC NORMOCYTIC ANAEMIA 12 0.0040
144 LOGORRHOEA 14 0.0040
145 SNORING 15 0.0040
146 RASH MORBILLIFORM 11 0.0040
147 DUODENITIS 12 0.0039
148 OLIGOHYDRAMNIOS 13 0.0039
149 HEPATOSPLENOMEGALY 10 0.0039
150 BLOOD PRESSURE ABNORMAL 77 0.0039
151 LIPOMA 10 0.0039
152 CARDIAC VALVE DISEASE 22 0.0038
153 HEAD DISCOMFORT 68 0.0038
154 ASTHMATIC CRISIS 14 0.0038
155 ECONOMIC PROBLEM 58 0.0038
156 VENTRICULAR FIBRILLATION 42 0.0038
157 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 36 0.0038
158 HYPERPHAGIA 15 0.0038
159 CARDIOMYOPATHY 55 0.0037
160 VITAMIN B12 DEFICIENCY 15 0.0037
161 MELANOCYTIC NAEVUS 16 0.0036
162 ATRIOVENTRICULAR BLOCK 28 0.0036
163 HYPERGLYCAEMIA 131 0.0036
164 HYPERPARATHYROIDISM SECONDARY 9 0.0036
165 HYPERTHYROIDISM 52 0.0036
166 ISCHAEMIC CARDIOMYOPATHY 11 0.0036
167 ATRIOVENTRICULAR BLOCK COMPLETE 24 0.0036
168 EXTRASYSTOLES 25 0.0036
169 POTENTIATING DRUG INTERACTION 12 0.0036
170 ACUTE PULMONARY OEDEMA 20 0.0036
171 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 22 0.0036
172 PSYCHOMOTOR RETARDATION 10 0.0036
173 SKIN HYPERTROPHY 10 0.0036
174 CHOLECYSTITIS 42 0.0035
175 ATELECTASIS 34 0.0035
176 DIVERTICULUM 25 0.0035
177 CARDIOGENIC SHOCK 50 0.0035
178 HYPOKALAEMIA 160 0.0035
179 RENAL FAILURE ACUTE 147 0.0035
180 PULMONARY HYPERTENSION 72 0.0035
181 HAEMODIALYSIS 29 0.0034
182 HAEMOTHORAX 10 0.0034
183 HYPERSENSITIVITY VASCULITIS 9 0.0034
184 PERIPHERAL VENOUS DISEASE 14 0.0034
185 UMBILICAL HERNIA 16 0.0034
186 SPINAL PAIN 40 0.0034
187 LARYNGEAL OEDEMA 21 0.0034
188 VENTRICULAR TACHYCARDIA 56 0.0034
189 ANURIA 29 0.0034
190 MYOCARDIAL ISCHAEMIA 38 0.0033
191 SPINAL CORD COMPRESSION 13 0.0033
192 CORONARY ARTERY DISEASE 101 0.0033
193 CARDIOPULMONARY FAILURE 13 0.0033
194 OESOPHAGITIS 36 0.0033
195 RENAL CYST 26 0.0033
196 RALES 19 0.0033
197 INTRACARDIAC THROMBUS 10 0.0033
198 AMYLASE INCREASED 12 0.0032
199 AFFECT LABILITY 31 0.0032
200 SINUS BRADYCARDIA 31 0.0032
201 ARTERIOSCLEROSIS 30 0.0032
202 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
203 ERYSIPELAS 16 0.0032
204 CARDIAC FAILURE CONGESTIVE 254 0.0032
205 FACE INJURY 12 0.0032
206 HYPOVOLAEMIC SHOCK 15 0.0031
207 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32 0.0031
208 HYPERLIPIDAEMIA 37 0.0031
209 PELVIC FRACTURE 24 0.0031
210 SPINAL OSTEOARTHRITIS 27 0.0031
211 APPARENT DEATH 11 0.0031
212 HEPATOMEGALY 30 0.0030
213 HYPERKALAEMIA 107 0.0030
214 LOCALISED OEDEMA 14 0.0030
215 SUDDEN DEATH 32 0.0030
216 APATHY 44 0.0030
217 BLOOD CULTURE POSITIVE 9 0.0030
218 HYPOTONIA 30 0.0030
219 HYPERCHOLESTEROLAEMIA 29 0.0030
220 CANDIDIASIS 12 0.0030
221 PERONEAL NERVE PALSY 17 0.0030
222 OVERWEIGHT 16 0.0030
223 RHINITIS 24 0.0030
224 ATRIOVENTRICULAR BLOCK SECOND DEGREE 9 0.0030
225 HYPONATRAEMIA 167 0.0030
226 DYSLIPIDAEMIA 15 0.0030
227 HEPATIC CYST 10 0.0029
228 CEREBRAL ISCHAEMIA 15 0.0029
229 DIFFICULTY IN WALKING 10 0.0029
230 ANGINA PECTORIS 83 0.0029
231 RESPIRATORY RATE INCREASED 25 0.0028
232 BEDRIDDEN 37 0.0028
233 HEPATIC PAIN 12 0.0028
234 INTERVERTEBRAL DISC DISORDER 12 0.0028
235 NEPHROGENIC ANAEMIA 13 0.0028
236 ALCOHOLISM 12 0.0028
237 PROSTATOMEGALY 11 0.0028
238 RESPIRATORY ACIDOSIS 11 0.0028
239 VISUAL DISTURBANCE 16 0.0028
240 YELLOW SKIN 13 0.0028
241 OBESITY 44 0.0028
242 SCLERODERMA 10 0.0027
243 INTERNATIONAL NORMALISED RATIO DECREASED 11 0.0027
244 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
245 CARDIAC FAILURE 216 0.0027
246 PULMONARY CONGESTION 35 0.0027
247 INTERVERTEBRAL DISC PROTRUSION 58 0.0027
248 ACUTE MYOCARDIAL INFARCTION 78 0.0026
249 OCCUPATIONAL EXPOSURE TO PRODUCT 17 0.0026
250 BREATH SOUNDS ABNORMAL 13 0.0026
251 URINE OUTPUT DECREASED 23 0.0026
252 INGUINAL HERNIA 16 0.0026
253 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
254 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
255 SINUS TACHYCARDIA 37 0.0026
256 ARRHYTHMIA 123 0.0026
257 HYPOPNOEA 9 0.0026
258 CHOLELITHIASIS 85 0.0026
259 PULMONARY OEDEMA 116 0.0026
260 TACHYPNOEA 35 0.0026
261 HAEMORRHAGIC STROKE 20 0.0026
262 HYPERTENSION 542 0.0026
263 BLOOD POTASSIUM INCREASED 41 0.0025
264 SINUS HEADACHE 15 0.0025
265 EJECTION FRACTION DECREASED 39 0.0025
266 PROTHROMBIN TIME PROLONGED 15 0.0025
267 HAEMORRHAGIC ANAEMIA 11 0.0025
268 EMPHYSEMA 25 0.0025
269 CAROTID ARTERY OCCLUSION 9 0.0025
270 BLOOD PRESSURE FLUCTUATION 59 0.0025
271 APNOEA 19 0.0024
272 GLAUCOMA 47 0.0024
273 FEAR 65 0.0024
274 HEPATIC STEATOSIS 45 0.0024
275 DUODENAL ULCER 17 0.0024
276 MULTIPLE ORGAN DYSFUNCTION SYNDROME 68 0.0024
277 RENAL FAILURE 318 0.0024
278 NOCTURIA 29 0.0024
279 BRONCHOSPASM 34 0.0024
280 LUNG INFILTRATION 21 0.0024
281 END STAGE RENAL DISEASE 43 0.0024
282 ABASIA 58 0.0023
283 RESPIRATORY DISORDER 70 0.0023
284 PERIPHERAL COLDNESS 32 0.0023
285 SPINAL DISORDER 22 0.0023
286 CARDIO-RESPIRATORY ARREST 97 0.0023
287 TORSADE DE POINTES 18 0.0023
288 RENAL INJURY 68 0.0023
289 RESPIRATORY DISTRESS 63 0.0023
290 MENISCUS INJURY 14 0.0023
291 HYDRONEPHROSIS 17 0.0023
292 JOINT DISLOCATION 24 0.0023
293 RESTLESSNESS 83 0.0023
294 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
295 BLOOD CREATINE INCREASED 10 0.0023
296 ATRIAL FLUTTER 18 0.0023
297 CATHETERISATION CARDIAC 10 0.0023
298 CREATININE RENAL CLEARANCE DECREASED 9 0.0022
299 HYPOVOLAEMIA 13 0.0022
300 BLOOD CREATININE INCREASED 145 0.0022
301 METABOLIC ACIDOSIS 71 0.0022
302 PROTEINURIA 42 0.0022
303 BRADYCARDIA 117 0.0022
304 HYPERURICAEMIA 9 0.0022
305 GENERALISED OEDEMA 27 0.0022
306 HYPERKERATOSIS 12 0.0022
307 ACUTE CORONARY SYNDROME 18 0.0022
308 EOSINOPHILIA 38 0.0022
309 IRON DEFICIENCY ANAEMIA 20 0.0022
310 HYPOCALCAEMIA 41 0.0022
311 ARTERIAL OCCLUSIVE DISEASE 17 0.0022
312 BLOOD TRIGLYCERIDES INCREASED 38 0.0021
313 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 11 0.0021
314 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
315 FEELING OF DESPAIR 10 0.0021
316 HYPOGLYCAEMIA 104 0.0021
317 NEPHROPATHY 20 0.0021
318 ACUTE RESPIRATORY FAILURE 41 0.0021
319 LACTIC ACIDOSIS 69 0.0021
320 SKIN TIGHTNESS 10 0.0021
321 OEDEMA PERIPHERAL 259 0.0021
322 LUNG INFECTION 33 0.0021
323 CORONARY ARTERY OCCLUSION 29 0.0021
324 LEUKOCYTOSIS 38 0.0021
325 SALIVARY HYPERSECRETION 21 0.0021
326 MYOCARDITIS 24 0.0021
327 SHOCK 48 0.0021
328 HEPARIN-INDUCED THROMBOCYTOPENIA 10 0.0020
329 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
330 BLOOD PRESSURE INCREASED 309 0.0020
331 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0020
332 HYDROCEPHALUS 11 0.0020
333 COGNITIVE DISORDER 94 0.0020
334 HAEMATOMA 52 0.0020
335 CIRCULATORY COLLAPSE 34 0.0020
336 DENTAL CARIES 22 0.0020
337 CARDIAC ARREST 163 0.0020
338 HAEMATOCRIT DECREASED 39 0.0020
339 BLOOD SODIUM DECREASED 37 0.0020
340 ACIDOSIS 15 0.0020
341 SUBDURAL HAEMATOMA 28 0.0020
342 ENCEPHALOPATHY 48 0.0020
343 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
344 HEMIPARESIS 33 0.0019
345 DIABETES MELLITUS 148 0.0019
346 HYPOMAGNESAEMIA 27 0.0019
347 STOMACH DISCOMFORT 10 0.0019
348 HYPOXIA 68 0.0019
349 HEMIPLEGIA 16 0.0019
350 OXYGEN SATURATION DECREASED 108 0.0019
351 PULMONARY HAEMORRHAGE 15 0.0019
352 ORAL DISORDER 14 0.0019
353 RESPIRATORY FAILURE 139 0.0019
354 BLOOD URIC ACID INCREASED 11 0.0019
355 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
356 GASTRITIS 50 0.0019
357 BURSITIS 23 0.0019
358 ORTHOSTATIC HYPOTENSION 33 0.0019
359 NEPHROPATHY TOXIC 21 0.0019
360 APHAGIA 9 0.0019
361 DECREASED INTEREST 11 0.0019
362 ANHEDONIA 49 0.0019
363 ANOREXIA 24 0.0019
364 PHARYNGITIS 23 0.0019
365 PNEUMONIA BACTERIAL 17 0.0019
366 DELIRIUM 64 0.0018
367 SLEEP APNOEA SYNDROME 35 0.0018
368 URINARY RETENTION 61 0.0018
369 LIPASE INCREASED 14 0.0018
370 RHABDOMYOLYSIS 76 0.0018
371 RENAL IMPAIRMENT 153 0.0018
372 BLOOD PRESSURE DECREASED 121 0.0018
373 OSTEOARTHRITIS 77 0.0018
374 DRUG INTERACTION 288 0.0018
375 DEAFNESS UNILATERAL 10 0.0018
376 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
377 FOOT DEFORMITY 20 0.0018
378 NERVE INJURY 20 0.0018
379 ISCHAEMIC STROKE 32 0.0018
380 FACIAL PAIN 16 0.0018
381 PLEURAL EFFUSION 109 0.0018
382 ATRIAL FIBRILLATION 174 0.0018
383 HYPOTHERMIA 18 0.0018
384 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
385 PNEUMOTHORAX 28 0.0018
386 PALLOR 48 0.0018
387 ANGIOEDEMA 78 0.0018
388 BLOOD POTASSIUM DECREASED 53 0.0018
389 NERVOUSNESS 92 0.0018
390 RESTLESS LEGS SYNDROME 32 0.0018
391 GENERALISED ERYTHEMA 10 0.0018
392 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
393 VENTRICULAR SEPTAL DEFECT 10 0.0017
394 HYPERTONIA 10 0.0017
395 HYPOTENSION 350 0.0017
396 BLOOD PRESSURE SYSTOLIC INCREASED 34 0.0017
397 HERPES VIRUS INFECTION 10 0.0017
398 DECREASED IMMUNE RESPONSIVENESS 17 0.0017
399 C-REACTIVE PROTEIN INCREASED 63 0.0017
400 PERIPHERAL SENSORY NEUROPATHY 10 0.0017
401 INCOHERENT 11 0.0017
402 HIATUS HERNIA 22 0.0017
403 SYNCOPE 170 0.0017
404 RENAL PAIN 18 0.0017
405 DIABETES MELLITUS INADEQUATE CONTROL 30 0.0017
406 PLEURISY 10 0.0017
407 DEHYDRATION 224 0.0017
408 MYOSITIS 15 0.0017
409 HYPOKINESIA 24 0.0017
410 MASS 23 0.0016
411 FOETAL GROWTH RESTRICTION 10 0.0016
412 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
413 COAGULOPATHY 27 0.0016
414 HEART RATE ABNORMAL 9 0.0016
415 ASPHYXIA 13 0.0016
416 DISORIENTATION 63 0.0016
417 POLYURIA 13 0.0016
418 PURPURA 14 0.0016
419 FLUID OVERLOAD 23 0.0016
420 INJURY 111 0.0016
421 RIGHT VENTRICULAR FAILURE 11 0.0016
422 RESPIRATORY ARREST 43 0.0016
423 ROTATOR CUFF SYNDROME 20 0.0016
424 MYOCARDIAL INFARCTION 271 0.0016
425 CHEST PAIN 286 0.0015
426 DYSPNOEA EXERTIONAL 58 0.0015
427 PARALYSIS 22 0.0015
428 PETECHIAE 16 0.0015
429 COMA 73 0.0015
430 RENAL TUBULAR NECROSIS 15 0.0015
431 CEREBROVASCULAR ACCIDENT 259 0.0015
432 RETINAL DETACHMENT 14 0.0015
433 MALNUTRITION 17 0.0015
434 BLOOD ALBUMIN DECREASED 12 0.0015
435 MEDICATION ERROR 83 0.0015
436 QUALITY OF LIFE DECREASED 20 0.0015
437 TOXIC SKIN ERUPTION 15 0.0015
438 FACE OEDEMA 25 0.0015
439 DIALYSIS 21 0.0015
440 LIVER FUNCTION TEST ABNORMAL 43 0.0015
441 TACHYCARDIA 131 0.0015
442 SEPTIC SHOCK 64 0.0015
443 HEPATIC FAILURE 44 0.0015
444 EATING DISORDER 31 0.0015
445 STEVENS-JOHNSON SYNDROME 32 0.0014
446 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
447 SKIN DISCOLOURATION 66 0.0014
448 PARKINSONISM 14 0.0014
449 PROCEDURAL COMPLICATION 11 0.0014
450 WOUND 40 0.0014
451 BONE DISORDER 26 0.0014
452 ANAEMIA 272 0.0014
453 CONGENITAL ANOMALY 11 0.0014
454 RESPIRATORY TRACT INFECTION 37 0.0014
455 BLINDNESS UNILATERAL 20 0.0014
456 LIGAMENT SPRAIN 14 0.0014
457 BLOOD CHOLESTEROL INCREASED 66 0.0014
458 IMMUNODEFICIENCY 21 0.0014
459 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
460 DERMATITIS CONTACT 16 0.0014
461 GENERAL PHYSICAL HEALTH DETERIORATION 162 0.0014
462 HERNIA 27 0.0014
463 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0014
464 GASTRIC HAEMORRHAGE 16 0.0014
465 MYOPATHY 12 0.0014
466 HEPATITIS ACUTE 9 0.0014
467 URINARY INCONTINENCE 41 0.0014
468 PANCREATITIS ACUTE 31 0.0014
469 BLISTER 77 0.0014
470 BLOOD GLUCOSE FLUCTUATION 15 0.0014
471 DEVICE RELATED INFECTION 21 0.0014
472 ABNORMAL BEHAVIOUR 54 0.0014
473 VERTIGO 83 0.0014
474 PRESYNCOPE 33 0.0014
475 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
476 DECUBITUS ULCER 11 0.0013
477 SKIN LESION 37 0.0013
478 POOR QUALITY SLEEP 29 0.0013
479 CONVULSION 77 0.0013
480 BREAST MASS 9 0.0013
481 CARDIOVASCULAR DISORDER 34 0.0013
482 HAEMORRHAGE INTRACRANIAL 20 0.0013
483 TYPE 2 DIABETES MELLITUS 45 0.0013
484 DYSSTASIA 39 0.0013
485 CHOKING 26 0.0013
486 HEPATIC CIRRHOSIS 25 0.0013
487 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
488 BLINDNESS 54 0.0013
489 APHASIA 40 0.0013
490 EMBOLISM 11 0.0013
491 NECK PAIN 74 0.0013
492 BODY TEMPERATURE INCREASED 27 0.0013
493 CONFUSIONAL STATE 213 0.0013
494 NEURALGIA 32 0.0013
495 SKIN ULCER 34 0.0013
496 DEPRESSED LEVEL OF CONSCIOUSNESS 52 0.0013
497 AORTIC ANEURYSM 10 0.0013
498 TROPONIN INCREASED 10 0.0013
499 EXOSTOSIS 12 0.0013
500 DROOLING 9 0.0013
501 CHOLESTASIS 25 0.0013
502 POST PROCEDURAL COMPLICATION 25 0.0013
503 DEAFNESS 34 0.0013
504 PERICARDIAL EFFUSION 30 0.0013
505 HAEMOLYSIS 10 0.0013
506 FORMICATION 9 0.0013
507 HEPATITIS 33 0.0013
508 DELUSION 20 0.0013
509 HEPATIC ENCEPHALOPATHY 12 0.0013
510 CARPAL TUNNEL SYNDROME 18 0.0013
511 CHROMATURIA 29 0.0013
512 CARDIAC DISORDER 120 0.0013
513 UNEVALUABLE EVENT 97 0.0013
514 FLANK PAIN 12 0.0013
515 ASPIRATION 14 0.0013
516 OEDEMA 69 0.0013
517 THROMBOCYTOPENIA 142 0.0013
518 GASTROINTESTINAL HAEMORRHAGE 106 0.0013
519 GASTRIC ULCER 24 0.0013
520 PULMONARY FIBROSIS 24 0.0012
521 ERECTILE DYSFUNCTION 32 0.0012
522 FAECES DISCOLOURED 27 0.0012
523 BLOOD CALCIUM DECREASED 14 0.0012
524 MUSCLE DISORDER 10 0.0012
525 GASTROENTERITIS 18 0.0012
526 HALLUCINATION, VISUAL 26 0.0012
527 HYPOACUSIS 53 0.0012
528 SHOCK HAEMORRHAGIC 10 0.0012
529 GASTROINTESTINAL INFECTION 11 0.0012
530 HEART RATE DECREASED 43 0.0012
531 SPEECH DISORDER 64 0.0012
532 ESCHERICHIA INFECTION 10 0.0012
533 ACUTE KIDNEY INJURY 186 0.0012
534 STAPHYLOCOCCAL INFECTION 40 0.0012
535 CHRONIC KIDNEY DISEASE 92 0.0012
536 LOCAL SWELLING 21 0.0012
537 SEPSIS 134 0.0012
538 DYSARTHRIA 45 0.0012
539 MENTAL DISORDER 52 0.0012
540 JOINT RANGE OF MOTION DECREASED 16 0.0012
541 UROSEPSIS 11 0.0012
542 GRAND MAL CONVULSION 11 0.0012
543 HYPOTHYROIDISM 38 0.0012
544 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
545 LOSS OF CONSCIOUSNESS 152 0.0012
546 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
547 TRANSIENT ISCHAEMIC ATTACK 40 0.0012
548 CANDIDA INFECTION 20 0.0012
549 DEFORMITY 11 0.0012
550 CATARACT 70 0.0012
551 THIRST 21 0.0012
552 DRUG TOXICITY 16 0.0012
553 PNEUMONIA 380 0.0012
554 INTRAOCULAR PRESSURE INCREASED 15 0.0012
555 GOUT 21 0.0012
556 DYSURIA 43 0.0012
557 INFLAMMATION 60 0.0012
558 FRACTURE 22 0.0012
559 HEART RATE IRREGULAR 26 0.0011
560 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
561 NIGHT SWEATS 37 0.0011
562 DRUG LEVEL INCREASED 19 0.0011
563 SEROTONIN SYNDROME 22 0.0011
564 MUSCULOSKELETAL PAIN 60 0.0011
565 HAND DEFORMITY 15 0.0011
566 NAIL DISORDER 10 0.0011
567 PULMONARY MASS 17 0.0011
568 HAEMATURIA 39 0.0011
569 RENAL DISORDER 53 0.0011
570 URINARY TRACT INFECTION 194 0.0011
571 FEEDING DISORDER 23 0.0011
572 EAR PAIN 22 0.0011
573 THROMBOTIC MICROANGIOPATHY 11 0.0011
574 CYST 14 0.0011
575 HAEMORRHOIDS 22 0.0011
576 HYPOAESTHESIA ORAL 17 0.0011
577 ASTHENIA 424 0.0011
578 METASTASES TO LUNG 13 0.0011
579 TRANSAMINASES INCREASED 25 0.0011
580 RASH MACULO-PAPULAR 25 0.0011
581 BODY HEIGHT DECREASED 12 0.0011
582 LEUKOPENIA 56 0.0011
583 EYELID OEDEMA 13 0.0011
584 LIVER FUNCTION TEST INCREASED 24 0.0011
585 PANCREATITIS 59 0.0011
586 MENTAL STATUS CHANGES 31 0.0011
587 BLOOD BILIRUBIN INCREASED 30 0.0011
588 BRAIN OEDEMA 14 0.0011
589 HAEMATEMESIS 28 0.0011
590 INFLUENZA 123 0.0011
591 THYROID DISORDER 17 0.0011
592 MUSCULOSKELETAL CHEST PAIN 17 0.0011
593 ARTHROPATHY 61 0.0011
594 MOVEMENT DISORDER 35 0.0011
595 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
596 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
597 SUBARACHNOID HAEMORRHAGE 11 0.0011
598 MOTOR DYSFUNCTION 11 0.0011
599 RETCHING 23 0.0011
600 DYSPNOEA 610 0.0011
601 CRYING 39 0.0011
602 WHITE BLOOD CELL COUNT INCREASED 41 0.0011
603 GAIT DISTURBANCE 204 0.0011
604 HYPERBILIRUBINAEMIA 11 0.0011
605 CEREBRAL HAEMORRHAGE 38 0.0011
606 ASCITES 31 0.0011
607 CELLULITIS 53 0.0011
608 EYE HAEMORRHAGE 14 0.0010
609 BLOOD MAGNESIUM DECREASED 9 0.0010
610 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
611 HAEMOGLOBIN DECREASED 107 0.0010
612 FLUID RETENTION 53 0.0010
613 BLOOD GLUCOSE INCREASED 196 0.0010
614 PHARYNGEAL OEDEMA 16 0.0010
615 HAEMOPTYSIS 29 0.0010
616 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
617 FALL 344 0.0010
618 HEPATOTOXICITY 23 0.0010
619 HEART RATE INCREASED 102 0.0010
620 SOMNOLENCE 206 0.0010
621 PAIN IN EXTREMITY 301 0.0010
622 AGITATION 75 0.0010
623 PROSTATIC SPECIFIC ANTIGEN INCREASED 14 0.0010
624 BODY TEMPERATURE DECREASED 10 0.0010
625 BACTERAEMIA 12 0.0010
626 ABDOMINAL PAIN 235 0.0010
627 ANAPHYLACTIC SHOCK 26 0.0010
628 COORDINATION ABNORMAL 14 0.0010
629 PLATELET COUNT INCREASED 13 0.0010
630 NODULE 13 0.0010
631 PYREXIA 344 0.0010
632 ORAL CANDIDIASIS 13 0.0010
633 IMMUNE SYSTEM DISORDER 13 0.0010
634 SLUGGISHNESS 10 0.0010
635 SUICIDE ATTEMPT 59 0.0010
636 EMOTIONAL DISORDER 30 0.0010
637 TENDON RUPTURE 12 0.0010
638 LIMB DISCOMFORT 30 0.0010
639 UNRESPONSIVE TO STIMULI 25 0.0010
640 KIDNEY INFECTION 19 0.0010
641 COUGH 271 0.0010
642 DEMENTIA 27 0.0010
643 BACTERIAL INFECTION 18 0.0010
644 PRODUCTIVE COUGH 46 0.0010
645 VISUAL ACUITY REDUCED 32 0.0010
646 DIARRHOEA HAEMORRHAGIC 9 0.0010
647 CYTOMEGALOVIRUS INFECTION 16 0.0010
648 HYPERHIDROSIS 124 0.0010
649 SINUS CONGESTION 13 0.0010
650 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
651 WEIGHT FLUCTUATION 10 0.0010
652 DERMATITIS ALLERGIC 12 0.0010
653 UPPER LIMB FRACTURE 19 0.0010
654 ARTHRITIS 75 0.0010
655 GALLBLADDER DISORDER 17 0.0010
656 SWELLING 89 0.0009
657 MOBILITY DECREASED 68 0.0009
658 INCONTINENCE 10 0.0009
659 BRONCHITIS 70 0.0009
660 ALANINE AMINOTRANSFERASE INCREASED 58 0.0009
661 CEREBRAL INFARCTION 23 0.0009
662 HYPOPHAGIA 24 0.0009
663 DISCOMFORT 57 0.0009
664 RIB FRACTURE 19 0.0009
665 PRODUCT PRESCRIBING ERROR 22 0.0009
666 MYOCLONUS 11 0.0009
667 TREMOR 153 0.0009
668 PNEUMONIA ASPIRATION 23 0.0009
669 MUSCLE RIGIDITY 11 0.0009
670 GASTROOESOPHAGEAL REFLUX DISEASE 74 0.0009
671 WRIST FRACTURE 11 0.0009
672 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
673 CONTUSION 87 0.0009
674 WEIGHT DECREASED 252 0.0009
675 FEELING COLD 25 0.0009
676 LUNG DISORDER 44 0.0009
677 NERVOUS SYSTEM DISORDER 28 0.0009
678 FOOT FRACTURE 17 0.0009
679 PALPITATIONS 105 0.0009
680 ANXIETY 255 0.0009
681 BLOOD GLUCOSE DECREASED 43 0.0009
682 MEMORY IMPAIRMENT 123 0.0009
683 DIZZINESS 446 0.0009
684 AMNESIA 58 0.0009
685 EYE INFECTION 10 0.0009
686 DYSPHAGIA 84 0.0009
687 HEAD INJURY 28 0.0009
688 EPISTAXIS 66 0.0009
689 LABORATORY TEST ABNORMAL 26 0.0009
690 PRURITUS GENERALISED 19 0.0009
691 SECRETION DISCHARGE 11 0.0009
692 SCIATICA 14 0.0009
693 EAR DISCOMFORT 9 0.0009
694 PANCYTOPENIA 49 0.0009
695 DIABETIC KETOACIDOSIS 21 0.0009
696 MUSCULOSKELETAL DISCOMFORT 15 0.0009
697 TINNITUS 40 0.0009
698 THERAPY NON-RESPONDER 39 0.0009
699 MELAENA 19 0.0009
700 DRUG-INDUCED LIVER INJURY 27 0.0009
701 RASH MACULAR 30 0.0009
702 DEPRESSION 195 0.0009
703 CONDITION AGGRAVATED 260 0.0009
704 COLD SWEAT 15 0.0009
705 NEPHROLITHIASIS 39 0.0008
706 LIMB INJURY 23 0.0008
707 DRUG ERUPTION 15 0.0008
708 ATAXIA 10 0.0008
709 VOMITING 396 0.0008
710 VIRAL INFECTION 28 0.0008
711 ANKLE FRACTURE 13 0.0008
712 POLLAKIURIA 35 0.0008
713 GAIT INABILITY 28 0.0008
714 PLATELET COUNT DECREASED 89 0.0008
715 PARAESTHESIA ORAL 12 0.0008
716 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
717 DYSPHONIA 48 0.0008
718 TOOTH LOSS 17 0.0008
719 JAUNDICE 22 0.0008
720 ABSCESS 13 0.0008
721 ABDOMINAL DISTENSION 85 0.0008
722 BLOOD GLUCOSE ABNORMAL 15 0.0008
723 DYSKINESIA 33 0.0008
724 DECREASED APPETITE 188 0.0008
725 HALLUCINATION 61 0.0008
726 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
727 SLEEP DISORDER 57 0.0008
728 GINGIVAL BLEEDING 11 0.0008
729 MUCOSAL INFLAMMATION 21 0.0008
730 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
731 SWOLLEN TONGUE 25 0.0008
732 MALAISE 351 0.0008
733 FEELING HOT 49 0.0008
734 BACK PAIN 185 0.0008
735 JOINT INJURY 17 0.0008
736 MUSCLE ATROPHY 10 0.0008
737 ROAD TRAFFIC ACCIDENT 33 0.0008
738 DRY MOUTH 64 0.0008
739 TREATMENT NONCOMPLIANCE 43 0.0008
740 CHILLS 91 0.0008
741 HAEMORRHAGE 81 0.0008
742 PNEUMONITIS 21 0.0008
743 WRONG TECHNIQUE IN DRUG USAGE PROCESS 28 0.0008
744 MOOD ALTERED 21 0.0008
745 RECTAL HAEMORRHAGE 33 0.0008
746 VISION BLURRED 105 0.0008
747 TOOTH DISORDER 17 0.0008
748 INTERSTITIAL LUNG DISEASE 37 0.0008
749 ERYTHEMA 157 0.0008
750 DERMATITIS 16 0.0008
751 HAEMATOCHEZIA 42 0.0008
752 MYELODYSPLASTIC SYNDROME 11 0.0008
753 SCAR 13 0.0008
754 FLATULENCE 43 0.0008
755 MUSCULAR WEAKNESS 86 0.0008
756 WEIGHT INCREASED 169 0.0008
757 ULCER 12 0.0008
758 DYSPEPSIA 74 0.0008
759 DRUG ADMINISTRATION ERROR 23 0.0007
760 SENSORY DISTURBANCE 12 0.0007
761 PRODUCT AVAILABILITY ISSUE 17 0.0007
762 PERIPHERAL SWELLING 115 0.0007
763 LIVER DISORDER 33 0.0007
764 FEMUR FRACTURE 23 0.0007
765 SKIN HAEMORRHAGE 11 0.0007
766 WHEEZING 44 0.0007
767 PAIN 455 0.0007
768 BONE PAIN 43 0.0007
769 THROMBOSIS 59 0.0007
770 CHEST DISCOMFORT 75 0.0007
771 LETHARGY 42 0.0007
772 EYE DISORDER 24 0.0007
773 ARTHRALGIA 303 0.0007
774 DIARRHOEA 469 0.0007
775 PERITONITIS 15 0.0007
776 HEPATIC FUNCTION ABNORMAL 27 0.0007
777 INJECTION SITE DISCOLOURATION 9 0.0007
778 DRUG DISPENSING ERROR 11 0.0007
779 CONSTIPATION 156 0.0007
780 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
781 PULMONARY EMBOLISM 67 0.0007
782 OSTEOPOROSIS 29 0.0007
783 FEELING ABNORMAL 168 0.0007
784 CONJUNCTIVITIS 13 0.0007
785 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
786 IRRITABLE BOWEL SYNDROME 15 0.0007
787 DIPLOPIA 18 0.0007
788 RASH ERYTHEMATOUS 33 0.0007
789 SEDATION 18 0.0007
790 EPILEPSY 21 0.0007
791 PARAESTHESIA 108 0.0007
792 COLITIS 26 0.0007
793 BLOOD URINE PRESENT 13 0.0007
794 METASTASES TO LIVER 12 0.0007
795 HYPOAESTHESIA 102 0.0007
796 ABDOMINAL PAIN UPPER 140 0.0007
797 LYMPHOCYTE COUNT DECREASED 12 0.0007
798 EAR INFECTION 18 0.0007
799 RED BLOOD CELL COUNT DECREASED 19 0.0007
800 TOOTHACHE 12 0.0007
801 LOCALISED INFECTION 16 0.0007
802 INSOMNIA 176 0.0007
803 CYSTITIS 21 0.0007
804 MUSCULOSKELETAL STIFFNESS 57 0.0006
805 OSTEONECROSIS OF JAW 16 0.0006
806 HYPERSENSITIVITY 120 0.0006
807 DYSGEUSIA 48 0.0006
808 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 31 0.0006
809 BURNING SENSATION 45 0.0006
810 MYALGIA 109 0.0006
811 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
812 NAUSEA 504 0.0006
813 HEADACHE 398 0.0006
814 DRUG INTOLERANCE 61 0.0006
815 DEEP VEIN THROMBOSIS 41 0.0006
816 SWELLING FACE 41 0.0006
817 HYPERSOMNIA 18 0.0006
818 EMOTIONAL DISTRESS 76 0.0006
819 DISEASE PROGRESSION 74 0.0006
820 INTENTIONAL OVERDOSE 40 0.0006
821 DRUG RESISTANCE 16 0.0006
822 TOXICITY TO VARIOUS AGENTS 105 0.0006
823 VISUAL IMPAIRMENT 77 0.0006
824 INJECTION SITE HAEMATOMA 9 0.0006
825 IRRITABILITY 37 0.0006
826 FLUSHING 62 0.0006
827 METASTASES TO BONE 10 0.0006
828 OSTEOMYELITIS 11 0.0006
829 EXTRAPYRAMIDAL DISORDER 15 0.0006
830 FEBRILE NEUTROPENIA 40 0.0006
831 BALANCE DISORDER 52 0.0006
832 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
833 SKIN DISORDER 20 0.0006
834 INFECTION 85 0.0006
835 INTESTINAL OBSTRUCTION 22 0.0006
836 GASTRIC DISORDER 20 0.0006
837 RASH PAPULAR 13 0.0006
838 IMPAIRED HEALING 19 0.0006
839 PHARMACEUTICAL PRODUCT COMPLAINT 15 0.0006
840 DIVERTICULITIS 16 0.0006
841 PSYCHOTIC DISORDER 17 0.0006
842 MOUTH ULCERATION 12 0.0006
843 MUSCLE SPASMS 104 0.0006
844 MOOD SWINGS 18 0.0006
845 ILL-DEFINED DISORDER 34 0.0006
846 SINUS DISORDER 11 0.0006
847 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
848 SPINAL FRACTURE 11 0.0005
849 DEPRESSED MOOD 29 0.0005
850 SURGERY 32 0.0005
851 DISTURBANCE IN ATTENTION 29 0.0005
852 PRURITUS 206 0.0005
853 SNEEZING 12 0.0005
854 PREMATURE BABY 16 0.0005
855 JOINT SWELLING 64 0.0005
856 LIVER INJURY 13 0.0005
857 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
858 INTENTIONAL PRODUCT MISUSE 46 0.0005
859 KNEE ARTHROPLASTY 11 0.0005
860 AGEUSIA 13 0.0005
861 DRUG PRESCRIBING ERROR 10 0.0005
862 AGGRESSION 26 0.0005
863 PRESCRIBED OVERDOSE 10 0.0005
864 EYE PAIN 29 0.0005
865 LUNG NEOPLASM MALIGNANT 21 0.0005
866 SKIN EXFOLIATION 43 0.0005
867 MENORRHAGIA 10 0.0005
868 LYMPHADENOPATHY 18 0.0005
869 FATIGUE 395 0.0005
870 EYE PRURITUS 17 0.0005
871 RASH PRURITIC 27 0.0005
872 HIP FRACTURE 16 0.0005
873 LACRIMATION INCREASED 15 0.0005
874 PRODUCT ADMINISTRATION ERROR 10 0.0005
875 SEIZURE 57 0.0005
876 GYNAECOMASTIA 15 0.0005
877 AGRANULOCYTOSIS 9 0.0005
878 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34 0.0005
879 NASAL CONGESTION 28 0.0005
880 ABNORMAL DREAMS 13 0.0005
881 RASH GENERALISED 12 0.0005
882 DRUG INEFFECTIVE 608 0.0005
883 ABDOMINAL DISCOMFORT 77 0.0005
884 EYE SWELLING 17 0.0005
885 HEPATIC ENZYME INCREASED 31 0.0005
886 MENTAL IMPAIRMENT 11 0.0005
887 WHITE BLOOD CELL COUNT DECREASED 49 0.0005
888 ASTHMA 51 0.0005
889 LIP SWELLING 15 0.0004
890 FUNGAL INFECTION 15 0.0004
891 OVERDOSE 97 0.0004
892 BREAST CANCER FEMALE 12 0.0004
893 THROAT TIGHTNESS 12 0.0004
894 BONE MARROW FAILURE 9 0.0004
895 OCULAR HYPERAEMIA 21 0.0004
896 NEUTROPENIA 60 0.0004
897 RHEUMATOID ARTHRITIS 50 0.0004
898 PANIC ATTACK 16 0.0004
899 ACCIDENTAL OVERDOSE 16 0.0004
900 ANAPHYLACTIC REACTION 24 0.0004
901 NASOPHARYNGITIS 80 0.0004
902 NIGHTMARE 15 0.0004
903 PROCEDURAL PAIN 12 0.0004
904 OROPHARYNGEAL PAIN 40 0.0004
905 FOETAL EXPOSURE DURING PREGNANCY 35 0.0004
906 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
907 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
908 GASTROINTESTINAL DISORDER 38 0.0004
909 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
910 INFUSION RELATED REACTION 28 0.0004
911 ECZEMA 22 0.0004
912 EYE IRRITATION 24 0.0004
913 FIBROMYALGIA 10 0.0004
914 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
915 NEUROPATHY PERIPHERAL 39 0.0004
916 SINUSITIS 42 0.0004
917 APPLICATION SITE PAIN 9 0.0004
918 DRUG EFFECT DECREASED 22 0.0004
919 URTICARIA 68 0.0004
920 WITHDRAWAL SYNDROME 17 0.0004
921 THROAT IRRITATION 18 0.0004
922 OSTEONECROSIS 13 0.0004
923 NEUTROPHIL COUNT DECREASED 16 0.0004
924 VAGINAL HAEMORRHAGE 17 0.0004
925 PAIN IN JAW 11 0.0004
926 DRUG EFFECT INCOMPLETE 14 0.0004
927 SUICIDAL IDEATION 35 0.0004
928 APPLICATION SITE ERYTHEMA 10 0.0004
929 JOINT STIFFNESS 10 0.0004
930 RASH 166 0.0004
931 DISEASE RECURRENCE 18 0.0004
932 NEOPLASM MALIGNANT 25 0.0004
933 NEOPLASM PROGRESSION 13 0.0004
934 INCORRECT DOSE ADMINISTERED 85 0.0004
935 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 67 0.0004
936 RHINORRHOEA 24 0.0004
937 PRODUCT USE IN UNAPPROVED INDICATION 92 0.0004
938 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
939 ALOPECIA 71 0.0004
940 PSORIASIS 47 0.0004
941 HOT FLUSH 27 0.0004
942 GASTRIC CANCER 9 0.0004
943 ANGER 12 0.0004
944 DRUG WITHDRAWAL SYNDROME 31 0.0004
945 THERAPEUTIC RESPONSE DECREASED 21 0.0003
946 MULTIPLE SCLEROSIS RELAPSE 23 0.0003
947 PRODUCT USE ISSUE 63 0.0003
948 MULTIPLE SCLEROSIS 16 0.0003
949 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
950 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
951 INJECTION SITE PRURITUS 22 0.0003
952 OFF LABEL USE 285 0.0003
953 DRUG ABUSE 27 0.0003
954 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
955 STOMATITIS 19 0.0003
956 HERPES ZOSTER 18 0.0003
957 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
958 DEATH 268 0.0003
959 DRY SKIN 39 0.0003
960 INFLUENZA LIKE ILLNESS 24 0.0003
961 INJECTION SITE ERYTHEMA 36 0.0003
962 EXPOSURE DURING PREGNANCY 17 0.0003
963 PSORIATIC ARTHROPATHY 11 0.0003
964 INJECTION SITE MASS 10 0.0003
965 PRODUCT SUBSTITUTION ISSUE 15 0.0003
966 PRODUCT DOSE OMISSION 17 0.0003
967 DRUG DOSE OMISSION 43 0.0003
968 ILLNESS 25 0.0002
969 DRY EYE 12 0.0002
970 PRODUCT QUALITY ISSUE 30 0.0002
971 BREAST CANCER 20 0.0002
972 INJECTION SITE SWELLING 16 0.0002
973 COVID-19 36 0.0002
974 DEVICE MALFUNCTION 14 0.0002
975 TREATMENT FAILURE 16 0.0002
976 DRUG DEPENDENCE 31 0.0002
977 UNDERDOSE 14 0.0002
978 DERMATITIS ATOPIC 10 0.0002
979 PROSTATE CANCER 15 0.0002
980 INJECTION SITE PAIN 56 0.0002
981 ADVERSE DRUG REACTION 16 0.0002
982 HOSPITALISATION 27 0.0002
983 PRODUCT DOSE OMISSION ISSUE 51 0.0002
984 SKIN BURNING SENSATION 12 0.0002
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
986 ADVERSE EVENT 14 0.0002
987 MIGRAINE 13 0.0001
988 COMPLETED SUICIDE 10 0.0001
989 INJECTION SITE HAEMORRHAGE 9 0.0001
990 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
991 NO ADVERSE EVENT 10 0.0001